Literature DB >> 31076724

ZBP1 mediates interferon-induced necroptosis.

Daowei Yang1, Yaoji Liang1,2,3,4, Shubo Zhao1, Yan Ding1, Qiuyu Zhuang1, Qilin Shi1, Tingting Ai1, Su-Qin Wu1, Jiahuai Han5.   

Abstract

Interferons (IFNs) play an important role in immunomodulatory and antiviral functions. IFN-induced necroptosis has been reported in cells deficient in receptor-interacting protein kinase 1 (RIPK1), Fas-associated protein with death domain (FADD), or caspase-8, but the mechanism is largely unknown. Here, we report that the DNA-dependent activator of IFN regulatory factors (ZBP1, also known as DAI) is required for both type I (β) and type II (γ) IFN-induced necroptosis. We show that L929 fibroblast cells became susceptible to IFN-induced necroptosis when RIPK1, FADD, or Caspase-8 was genetically deleted, confirming the antinecroptotic role of these proteins in IFN signaling. We found that the pronecroptotic signal from IFN stimulation depends on new protein synthesis and identified ZBP1, an IFN-stimulated gene (ISG) product, as the de novo synthesized protein that triggers necroptosis in IFN-stimulated cells. The N-terminal domain (ND) of ZBP1 is important for ZBP1-ZBP1 homointeraction, and its RHIM domain in the C-terminal region interacts with RIPK3 to initiate RIPK3-dependent necroptosis. The antinecroptotic function of RIPK1, FADD, and caspase-8 in IFN-treated cells is most likely executed by caspase-8-mediated cleavage of RIPK3, since the inhibitory effect on necroptosis was eliminated when the caspase-8 cleavage site in RIPK3 was mutated. ZBP1-mediated necroptosis in IFN-treated cells is likely physiologically relevant, as ZBP1 KO mice were significantly protected against acute systemic inflammatory response syndrome (SIRS) induced by TNF + IFN-γ.

Entities:  

Keywords:  ZBP1; interferon; necroptosis

Mesh:

Substances:

Year:  2019        PMID: 31076724      PMCID: PMC7109092          DOI: 10.1038/s41423-019-0237-x

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  52 in total

Review 1.  Complex modulation of cell type-specific signaling in response to type I interferons.

Authors:  Anette H H van Boxel-Dezaire; M R Sandhya Rani; George R Stark
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

Review 2.  Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors.

Authors:  Kenya Honda; Akinori Takaoka; Tadatsugu Taniguchi
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

Review 3.  Fifty years of interferon research: aiming at a moving target.

Authors:  Jan Vilcek
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

Review 4.  JAK-STAT signaling: from interferons to cytokines.

Authors:  Christian Schindler; David E Levy; Thomas Decker
Journal:  J Biol Chem       Date:  2007-05-14       Impact factor: 5.157

Review 5.  The IFN gamma receptor: a paradigm for cytokine receptor signaling.

Authors:  E A Bach; M Aguet; R D Schreiber
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

6.  NF-kappaB protects cells from gamma interferon-induced RIP1-dependent necroptosis.

Authors:  Roshan J Thapa; Suresh H Basagoudanavar; Shoko Nogusa; Krishna Irrinki; Karthik Mallilankaraman; Michael J Slifker; Amer A Beg; Muniswamy Madesh; Siddharth Balachandran
Journal:  Mol Cell Biol       Date:  2011-05-16       Impact factor: 4.272

7.  Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.

Authors:  Tobias Marcello; Arash Grakoui; Giovanna Barba-Spaeth; Erica S Machlin; Sergei V Kotenko; Margaret R MacDonald; Charles M Rice
Journal:  Gastroenterology       Date:  2006-10-01       Impact factor: 22.682

Review 8.  Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation.

Authors:  Jacob Piehler; Christoph Thomas; K Christopher Garcia; Gideon Schreiber
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

Review 9.  Interferons, interferon-like cytokines, and their receptors.

Authors:  Sidney Pestka; Christopher D Krause; Mark R Walter
Journal:  Immunol Rev       Date:  2004-12       Impact factor: 12.988

Review 10.  The bacterial pathogen Listeria monocytogenes and the interferon family: type I, type II and type III interferons.

Authors:  Olivier Dussurget; Hélène Bierne; Pascale Cossart
Journal:  Front Cell Infect Microbiol       Date:  2014-04-28       Impact factor: 5.293

View more
  39 in total

1.  Glucocorticoids limit lipopolysaccharide-induced lethal inflammation by a double control system.

Authors:  Kelly Van Looveren; Steven Timmermans; Tineke Vanderhaeghen; Charlotte Wallaeys; Marlies Ballegeer; Jolien Souffriau; Melanie Eggermont; Jolien Vandewalle; Lise Van Wyngene; Karolien De Bosscher; Claude Libert
Journal:  EMBO Rep       Date:  2020-05-08       Impact factor: 8.807

2.  ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis.

Authors:  Rajendra Karki; Balamurugan Sundaram; Bhesh Raj Sharma; SangJoon Lee; R K Subbarao Malireddi; Lam Nhat Nguyen; Shelbi Christgen; Min Zheng; Yaqiu Wang; Parimal Samir; Geoffrey Neale; Peter Vogel; Thirumala-Devi Kanneganti
Journal:  Cell Rep       Date:  2021-10-19       Impact factor: 9.423

Review 3.  Regulated cell death (RCD) in cancer: key pathways and targeted therapies.

Authors:  Fu Peng; Minru Liao; Rui Qin; Shiou Zhu; Cheng Peng; Leilei Fu; Yi Chen; Bo Han
Journal:  Signal Transduct Target Ther       Date:  2022-08-13

4.  Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma.

Authors:  Nicholas J Haradhvala; Mark B Leick; Katie Maurer; Satyen H Gohil; Rebecca C Larson; Ning Yao; Kathleen M E Gallagher; Katelin Katsis; Matthew J Frigault; Jackson Southard; Shuqiang Li; Michael C Kann; Harrison Silva; Max Jan; Kahn Rhrissorrakrai; Filippo Utro; Chaya Levovitz; Raquel A Jacobs; Kara Slowik; Brian P Danysh; Kenneth J Livak; Laxmi Parida; Judith Ferry; Caron Jacobson; Catherine J Wu; Gad Getz; Marcela V Maus
Journal:  Nat Med       Date:  2022-09-12       Impact factor: 87.241

Review 5.  The regulation of necroptosis by post-translational modifications.

Authors:  Yanxiang Meng; Jarrod J Sandow; Peter E Czabotar; James M Murphy
Journal:  Cell Death Differ       Date:  2021-01-18       Impact factor: 15.828

6.  ZBP1 not RIPK1 mediates tumor necroptosis in breast cancer.

Authors:  Jin Young Baik; Zhaoshan Liu; Delong Jiao; Hyung-Joon Kwon; Jiong Yan; Chamila Kadigamuwa; Moran Choe; Ross Lake; Michael Kruhlak; Mayank Tandon; Zhenyu Cai; Swati Choksi; Zheng-Gang Liu
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

7.  TDP-43 prevents endogenous RNAs from triggering a lethal RIG-I-dependent interferon response.

Authors:  William Dunker; Xiang Ye; Yang Zhao; Lanxi Liu; Antiana Richardson; John Karijolich
Journal:  Cell Rep       Date:  2021-04-13       Impact factor: 9.423

8.  An IFN-STAT Axis Augments Tissue Damage and Inflammation in a Mouse Model of Crohn's Disease.

Authors:  Iris Stolzer; Anja Dressel; Mircea T Chiriac; Markus F Neurath; Claudia Günther
Journal:  Front Med (Lausanne)       Date:  2021-05-20

9.  Vaccinia virus E3 prevents sensing of Z-RNA to block ZBP1-dependent necroptosis.

Authors:  Heather Koehler; Samantha Cotsmire; Ting Zhang; Siddharth Balachandran; Jason W Upton; Jeffery Langland; Daniel Kalman; Bertram L Jacobs; Edward S Mocarski
Journal:  Cell Host Microbe       Date:  2021-06-29       Impact factor: 31.316

Review 10.  Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome-with a preliminary reference to SARS-CoV-2 pneumonia.

Authors:  Walter Gottlieb Land
Journal:  Genes Immun       Date:  2021-06-17       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.